U.S. Plans FDA Presence In China Next Month
This article was originally published in PharmAsia News
Executive Summary
The top U.S. health official says the FDA plans to locate personnel in China beginning in May, subject to approval by Chinese authorities. Health and Human Services Secretary Mike Leavitt said in an interview in Singapore the first U.S. FDA office in China will be headed by the current director of the HHS Asia and the Pacific office, Christopher Hickey. Hickey said the FDA is still awaiting final approval from China for an FDA office there. Leavitt said FDA presence would allow not only inspections, but an ability to build capacity and maintain relationships with China's regulators. (Click here for more